Sareum - Specialists in Structure-based Drug Discovery
Print the page Smaller text Larger text

 

Information Disclosure

 

The following information is disclosed for the purposes of Rule 26 of the AIM Rules for Companies

Sareum is incorporated in, and operates from, the UK

Sareum trades as Sareum Limited and is registered in England and Wales with Company Numbers:

Sareum Limited 04863659
Sareum Holdings plc 05147578


The registered address is:
2 Iconix Park
Cambridge, CB22 3EG
United Kingdom


The VAT Number for the group is:
GB 844 2941 18 

 

 Articles of Association   

 Admission Document    

 Corporate Governance

 

Financial Results Available as PDF Documents:

 
  Interim Results 2007/8    Preliminary Results 2007/8   Annual Report 2008
  Interim Results 2006/7    Preliminary Results 2006/7   Annual Report 2007
  Interim Results 2005/6

   Preliminary Results 2005/6

  Annual Report 2006
  Interim Results 2004/5    Preliminary Results 2004/5   Annual Report 2005

 

Share Information

(Last updated Dec 22 2008)

 

Sareum Holdings plc shares are listed on the AIM market of the London Stock Exchange, under the symbol SAR.  Share Price information is available at the London Stock Exchange

The total number of shares in issue is: 818,097,713.  16.3% are not in public hands

 

Significant Shareholders

  Holding %  

Mr & Mrs Leonard Licht

9.8%

Mr Leonard Licht is a Partner of Hg Capital, a former founding director and Vice Chairman of Mercury Asset Management and previous Deputy Chairman of Jupiter Tyndall Group.

 

Drs John & Valerie Reader

5.3%

Founder & VP, Chemistry

 

Dr Tim Mitchell

5.2%

Founder & CEO

 

Dr David Williams

5.2%

 

 
Mr Joseph Craven 4.6%

 

 

   
     

 



Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701